AbolerIS Pharma logo

AbolerIS Pharma

0 followers

AbolerIS Pharma will develop novel and unique therapeutic approaches to induce immune tolerance and preserves useful immune responses in inflammatory, autoimmune and degenerative diseases. Anti-CD45RC monoclonal antibody to deplete effector T cells and preserve regulatory and memory T cells. IL-34... Read more

Industries

Headquarters

Nantes, France

Employees

1-10

Links


Org chart

Collapse
Benoit Moreaux
Head of Operations-Part Time
Philippe Alen
Chief Business Officer (fractional)
Tomas Van Dyck
Chief Financial Officer

Board & advisors

Olivier Van de Steen
Medical Advisor
Guy Heynen
Director
Hans-Dieter Volk
Scientific Advisor